Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases

Biomedicines
02 June 2023
https://pubmed.ncbi.nlm.nih.gov/37371715/

Leonard Weinstock, MD - Irritable Bowel Syndrome: The Roles of Small Intestinal Bacterial Overgrowth (SIBO) and Mucosal/Systemic Inflammation (2017 Conference) (LDN; low dose naltrexone)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study

BMJ Open
08 April 2022
https://pubmed.ncbi.nlm.nih.gov/35396307/

Depression in Fibromyalgia Patients May Require Low-Dose Naltrexone to Respond: A Case Report

Cureus
28 February 2022
https://www.cureus.com/articles/85269-depression-in-fibromyalgia-patients-may-require-low-dose-naltrexone-to-respond-a-case-report

Jill Smith, MD - Inflammatory Bowel Disease (2013 Conference) (LDN, low dose naltrexone)